阿比特龍

Men in both studies were given 1000mg of abiraterone daily. 兩個研究中的男患者每日均口服1000mg阿比特龍。

Men in both studies were gien 1000mg of abiraterone daily. 兩個研究中的男患者每日均口服1000mg阿比特龍。

Phase III trial of abiraterone is planned for next year. 阿比特龍的III期試驗計劃在明年進行。

Ten of these men have seen PSA declines of more than 50% that have lasted at least 3 months from the start of taking abiraterone, with no major toxicities or adverse events. 其中10名患者在堅持服用阿比特龍至少3個月后，PSA下降超過50%25，沒有嚴重毒性或不良事件發(fā)生。

Ten of these men hae seen PSA declines of more than 50% that hae lasted at least 3 months from the start of taking abiraterone, with no major toxicities or aderse eents. 其中10名患者在堅持服用阿比特龍至少3個月后，PSA下降超過50%25，沒有嚴重毒性或不良事件發(fā)生。